Larry Cripe

  • 4082 Citations
  • 26 h-Index
1976 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.



Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials

Sayar, H., Cripe, L. D., Saliba, A. N., Abu Zaid, M., Konig, H. & Boswell, H. S., Feb 2019, In : Leukemia Research. 77, p. 30-33 4 p.

Research output: Contribution to journalLetter

3 Scopus citations

Long-term outcome of NPM1 mutated acute myeloid leukemia: A single-institution experience

Sayar, H., Bashardoust, P., Cripe, L., Chakraborty, S. & Bai, S., Feb 1 2017, In : American Journal of Hematology. 92, 2, p. E17-E18

Research output: Contribution to journalLetter

2 Scopus citations

Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome

Sokol, L., Cripe, L., Kantarjian, H., Sekeres, M. A., Parmar, S., Greenberg, P., Goldberg, S. L., Bhushan, V., Shammo, J., Hohl, R., Verma, A., Garcia-Manero, G., Li, Y. P., Lowe, A., Zhu, J. & List, A. F., Apr 1 2013, In : Leukemia. 27, 4, p. 977-980 4 p.

Research output: Contribution to journalLetter

21 Scopus citations

The storm before the calm

Cripe, L. D. & Shulman, L. N., Dec 1 2009, In : American Journal of Hematology/ Oncology. 8, 12

Research output: Contribution to journalLetter